Publications by authors named "Gil Santis"

Claim this Profile
O
Outcomes of thrombotic thrombocytopenic purpura patients submitted to therapeutic plasma exchange in a single center in Brazil.
Patrícia Oliveira Cunha Terra, Gil Cunha De Santis, Benedito de Pina Almeida Prado Júnior, Luciana Correa Oliveira

Hematol Transfus Cell Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome profiling reveals distinct alterations in the B-cell signature and dysregulation of peripheral B-cell subsets in sickle cell anemia patients.
Rafaela de Freitas Martins Felício, Luciana Ribeiro Jarduli-Maciel, Maritza Queiroz Salas Mosella, Felipe Campos Almeida, Keli Cristina de Lima, Gil Cunha de Santis

Exp Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photobiomodulation with laser and led on mesenchymal stem cells viability and wound closure in vitro.
Ana Paula Ferro, Rinaldo Roberto de Jesus Guirro, Maristela Delgado Orellana, Gil Cunha de Santis, Jayme Adriano Farina Junior

Lasers Med Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil.
Camila D Donadel, Gil C De Santis, Thiago E Gonçalves, Bruno G Pires, Leonardo C Palma

Bone Marrow Transplant· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Anemia tolerance mechanisms.
Roseny Dos Reis Rodrigues, Denise Menezes Brunetta, Lorena Costa, Bruno Deltreggia Benites, Mariana Munari Magnus, Gil Cunha De Santis

Hematol Transfus Cell Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Assessment and management of postoperative anemia.
Bruno Deltreggia Benites, Mariana Munari Magnus, Lorena Costa, Denise Menezes Brunetta, Roseny Dos Reis Rodriges, Gil Cunha De Santis

Hematol Transfus Cell Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Anemia tolerance.
Gil Cunha De Santis, Lorena Costa, Denise Menezes Brunetta, Mariana Munari Magnus, Bruno Deltreggia Benites

Hematol Transfus Cell Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Different Photobiomodulation Parameters on Multi-Potent Adipose Tissue Mesenchymal Cells .
Ana Paula Ferro, Rinaldo Roberto de Jesus Guirro, Cleber Ferraresi, Jonathan Celli, Maristela Delgado Orellana, Gil Cunha de Santis

Photobiomodul Photomed Laser Surg· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Umbilical Cord Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease.
Camila Derminio Donadel, Bruno Garcia Pires, Nathália Cristine André, Thalita Cristina Mello Costa, Maristela Delgado Orellana, Gil Cunha De Santis

Pharmaceuticals (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histo-blood group A is a risk factor for severe COVID-19.
Pedro M M Garibaldi, Luciana C Oliveira, Benedito A da Fonseca, Maria Auxiliadora-Martins, Carlos H Miranda, Gil C De Santis

Transfus Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI).
Alice T W Song, Vanderson Rocha, Alfredo Mendrone-Júnior, Rodrigo T Calado, Gil C De Santis

Lancet Reg Health Am· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response).
Gil C De Santis, Rodrigo T Calado

Emerg Infect Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic haematopoietic stem cell transplantation resets T- and B-cell compartments in sickle cell disease patients.
Luciana Ribeiro Jarduli-Maciel, Júlia Teixeira Cottas de Azevedo, Emmanuel Clave, Thalita Cristina de Mello Costa, Lucas Coelho Marlière Arruda, Gil Cunha De Santis

Clin Transl Immunology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
Gil C De Santis, Luciana Correa Oliveira, Pedro M M Garibaldi, Carlos E L Almado, Julio Croda

Emerg Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-lymphocyte ratio and D-dimer are biomarkers of death risk in severe COVID-19: A retrospective observational study.
Patrícia Oliveira Cunha Terra, Camila Dermínio Donadel, Luciana Correa Oliveira, Mayra Gonçalves Menegueti, Maria Auxiliadora-Martins, Gil Cunha De Santis

Health Sci Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients.
Júlia Teixeira Cottas de Azevedo, Thalita Cristina de Mello Costa, Keli Cristina Lima, Thiago Trovati Maciel, Patrícia Vianna Bonini Palma, Gil Cunha De Santis

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Infection in Sickle Cell Patients in a Developing Country: A Case Series.
Ana Cristina Silva-Pinto, Letícia Santos-Oliveira, Flávia Leite Souza Santos, Simone Kashima Haddad, Gil Cunha De Santis

Acta Haematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V: Manufacture and quality control.
Gil Cunha De Santis, Dante Mário Langhi Junior, Andreza Feitoza, Alfredo Mendrone Junior, José Mauro Kutner

Hematol Transfus Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VI: Accreditation process.
Gil Cunha De Santis, Eugênia Maria Amorim Ubiali, Ana Paula Rocha Diniz Zanelli, Alfredo Mendrone Junior, Andreza Feitoza

Hematol Transfus Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VII. Present and future of technologies for production of CAR cell therapies.
Rodrigo Nalio Ramos, Virginia Picanço-Castro, Theo Gremen M Oliveira, Alfredo Mendrone, Gil Cunha De Santis

Hematol Transfus Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Special article: compassionate use and clinical trial on CAR-T cells.
Gil Cunha De Santis

Hematol Transfus Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes and COVID-19: What we learned from the two ongoing pandemics.
Maria Teresa da Costa Gonçalves Torquato, Gil Cunha De Santis, Maria Lucia Zanetti

Rev Lat Am Enfermagem· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-COV-2: is it a risk for blood transfusion?
Dante Mário Langhi, Renato Cerqueira de Souza, Melca Barros, Gil Cunha De Santis, Simone Haddad Kashima

Hematol Transfus Cell Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19.
Gil Cunha De Santis, Alfredo Mendrone, Dante Langhi, Dimas Tadeu Covas, Antônio Fabron

Hematol Transfus Cell Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaso-occlusive crisis in a sickle cell patient after transfusion-transmitted dengue infection.
Flávia L S Santos, Svetoslav N Slavov, Rafael S Bezerra, Elaine V Santos, Ana C Silva-Pinto, Gil C De Santis

Transfusion· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis